To date, clinical tools for PCa diagnosis encompass digital rectal examination (DRE), serum prostate-specific antigen (PSA) testing, imaging techniques including transrectal ultrasound (TRUS) and magnetic resonance imaging (MRI), and biopsies [6]. The gene discussed is KLK3; the disease is posterior cortical atrophy.